Financial News for Vertex Pharmaceuticals, Incorporated (VRTX)
| VRTX | 3/12/2010 8:10PM | 52 Week Price Range | Market Capitalization | Dividend Yield | Recent Dividend |
|---|---|---|---|---|---|
| $43.46 | $25.94 — $44.24 | $8.7 Billion | n/a | n/a |
Want to Sharpen Your Investing?
Learn how Ockham can help investors make informed decisions and slice through the noise. Learn more about Ockham's services.
Explore Why Ockham?
Vertex Pharmaceuticals, Incorporated is in the news. Find out how this impacts VRTX trading on Ockham Research.
Fantastic numbers they put up. And some of these big drug stocks, of course, human genome. That's an amazing story. But there are others in the space as well. Vertex pharmaceutical, VRTX. I'd say that is the leadership area right now. It's not financials at all. They're not leading us down. They're just taking some of the air out of the financial balloon, although with my exposure, i'm in the faz, the double short financial, and i'm continue to trade soft. Let's switch gears here and talk about ford, which is topping the
- Since VRTX was mentioned on Power Lunch through right now, shares of Vertex Pharmaceuticals, Incorporated have appreciated 16.23%.
- Please visit the Power Lunch recap page for all the slices of the 27 stocks mentioned on just this one episode of the show.
- VRTX was mentioned 4 times on this episode alone, so visit the Power Lunch recap page for more information on other topics covered.
- Besides Vertex Pharmaceuticals, Incorporated's mention on Power Lunch it's also been discussed 4 times on various other business shows since then. You can also catch up on All financial news for Vertex Pharmaceuticals, Incorporated.